Debbie Lin - Vice President for Strategic Collaborations @ Caris Life Sciences

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

79,372

Primary Job Title Vice President for Strategic Collaborations
Primary Organization
Caris Life Sciences

Location Pasadena, California, United States
Regions Greater Los Angeles Area, West Coast, Western US
Gender Female

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Debbie W. Lin is based out of Pasadena, California and is the Vice President of Caris Life Sciences. Debbie previously worked at Boehringer Ingelheim Pharma as a Executive Director. Debbie W. Lin attended the Stanford University School of Engineering.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Optina Diagnostics	Boehringer Ingelheim Venture Fund	—	Series A - Optina Diagnostics	obfuscated obfuscation
obfuscated obfuscation	Bodyport	Boehringer Ingelheim Venture Fund	—	Series A - Bodyport	obfuscated obfuscation
obfuscated obfuscation	Wellth	Boehringer Ingelheim Venture Fund	Yes	Series A - Wellth	obfuscated obfuscation
obfuscated obfuscation	Wellth	Boehringer Ingelheim Venture Fund	—	Seed Round - Wellth	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Debbie Lin

is the

Vice President for Strategic Collaborations

Caris Life Sciences

. Additionally,

Debbie Lin

has had

past jobs including

Executive Director

Boehringer Ingelheim Venture Fund

Caris Life Sciences Vice President for Strategic Collaborations

Organization Name	Title At Company	Start Date	End Date
Boehringer Ingelheim Venture Fund	Executive Director	—	—
UCLA Anderson School of Management	Adjunct Faculty	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Debbie Lin

is the

Board Member

Wellth

Wellth Board MemberMay 2020

Related Hubs

Hub Name	CB Rank (Hub)
CPP Investments Portfolio Companies	34,506
Health Care Companies With More Than $100M in Revenue	2,531
United States Oncology Companies	17,873
Biotechnology Companies With More Than 1000 Employees	6,000
Perceptive Advisors Portfolio Companies	73,961
Biopharma Companies With More Than $10M in Revenue	37,198
Biotechnology Public Companies With More Than $1M in Revenue	23,353
Oncology Companies that Exited	34,035
Artificial Intelligence (AI) Companies With More Than $50M in Revenue	13,302
Health Care Public Companies With Less Than $500M in Revenue	21,824